Michael G. Ison, MD MS
@michaelisonmd.bsky.social
Transplant Infectious Diseases MD, clinical respiratory virologist and Editor-in-Chief of @TheTxIDJournal.bsky.social.
All opinions and tweets are my own.
All opinions and tweets are my own.
I had the HUGE honor of being the 40th Forbes Fellow - when I was the previous awardees, I was truly humbled. The ID community is incredible in Melbourne. @monashuniversity.bsky.social @unimelb.bsky.social @thedohertyinst.bsky.social @trubianojason.bsky.social @bradgardiner.bsky.social
November 15, 2025 at 12:13 AM
I had the HUGE honor of being the 40th Forbes Fellow - when I was the previous awardees, I was truly humbled. The ID community is incredible in Melbourne. @monashuniversity.bsky.social @unimelb.bsky.social @thedohertyinst.bsky.social @trubianojason.bsky.social @bradgardiner.bsky.social
Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight:
See next posts
See next posts
October 22, 2025 at 1:36 PM
Due to the USG Shutdown, I wasn’t able to attend or present @idweek.bsky.social. I was supposed to give the talk on top viral studies that will impact your practice. Here are the papers I was going to highlight:
See next posts
See next posts
Due to the US Government Shutdown, I will not be able to atted @IDWeek.bsky.social #IDWeek2025. I had worked on my 2 invited talks and so will share them.
My first talk was going to be about the epidemiology and clinical course of respiratory viral infections in the immunocompromised.
My first talk was going to be about the epidemiology and clinical course of respiratory viral infections in the immunocompromised.
October 21, 2025 at 4:05 PM
Due to the US Government Shutdown, I will not be able to atted @IDWeek.bsky.social #IDWeek2025. I had worked on my 2 invited talks and so will share them.
My first talk was going to be about the epidemiology and clinical course of respiratory viral infections in the immunocompromised.
My first talk was going to be about the epidemiology and clinical course of respiratory viral infections in the immunocompromised.
Excited to see the “Advances in Influenza Therapeutics” supplement out in @jidjournal.bsky.social - led by Fred Hayden and Rich Whitley, this supplement reviews what we know about antivirals and how they should be used for influenza.
academic.oup.com/jid/issue/23...
academic.oup.com/jid/issue/23...
Volume 232 Issue Supplement_3 | The Journal of Infectious Diseases | Oxford Academic
An official journal of the Infectious Diseases Society of America. Publishes research results on microbiology, immunology, and epidemiology; pathogenesis, diagnosis, and treatment of infectious diseas...
academic.oup.com
October 20, 2025 at 6:26 PM
Excited to see the “Advances in Influenza Therapeutics” supplement out in @jidjournal.bsky.social - led by Fred Hayden and Rich Whitley, this supplement reviews what we know about antivirals and how they should be used for influenza.
academic.oup.com/jid/issue/23...
academic.oup.com/jid/issue/23...
Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!
@thetxidjournal.bsky.social is seeking applications for those interested in joining the editorial team (onlinelibrary.wiley.com/page/journal...) as an Associate Editor. We are specifically seeking someone who has clinical and research experience focused on HSCT/Oncology ID for this position.
1/4
1/4
Transplant Infectious Disease Editorial Board
Michael G. Ison MD, MS, Washington, DC, USA
onlinelibrary.wiley.com
September 26, 2025 at 6:52 PM
Do you focus on HSCT/Oncology ID? Want to be part of the editorial team of @thetxidjournal.bsky.social? Please apply by October 17 for an open position as outlined in this link!
Reposted by Michael G. Ison, MD MS
check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with
@michaelisonmd.bsky.social
on this! #TxID doi.org/10.1016/j.jh...
@michaelisonmd.bsky.social
on this! #TxID doi.org/10.1016/j.jh...
Redirecting
doi.org
September 3, 2025 at 11:09 AM
check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with
@michaelisonmd.bsky.social
on this! #TxID doi.org/10.1016/j.jh...
@michaelisonmd.bsky.social
on this! #TxID doi.org/10.1016/j.jh...
The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.
September 17, 2025 at 2:24 AM
The ISRV AVG meeting kicked of by Fred Hayden giving the 2nd Roberts/Tisdale lecture on the clinical implications of antiviral resistance.
Excited to have this paper out! Demonstrates that the recipients of lung 🫁 tx for COVID-Associated Lung Injury (CALI) loose humoral protection and have unique cellular immune responses.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Identification of immune signatures associated with both SARS-CoV-2 infection and lung transplantation
Lung transplantation (lung-tx) offers the last life-saving option for patients with COVID-19-associated lung injury (CALI). We show that the RBD-speci…
www.sciencedirect.com
August 15, 2025 at 11:11 AM
Excited to have this paper out! Demonstrates that the recipients of lung 🫁 tx for COVID-Associated Lung Injury (CALI) loose humoral protection and have unique cellular immune responses.
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
Reposted by Michael G. Ison, MD MS
AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate.
ajt-transplant-id-exchange.squarespace.com
ajt-transplant-id-exchange.squarespace.com
July 10, 2025 at 7:21 PM
AJT’S new ID blog, TxIDExchange, is dedicated to sharing the latest ID updates, research, and guidelines relevant to the transplant community. We’re soliciting blog posts and comments from you and your colleagues and encourage you to participate.
ajt-transplant-id-exchange.squarespace.com
ajt-transplant-id-exchange.squarespace.com
Reposted by Michael G. Ison, MD MS
Don't miss the new @amjtransplant.bsky.social #TxID blog led by Emily Blumberg ajt-transplant-id-exchange.squarespace.com #wtc2025 @ast-idcop.bsky.social @ast-tyfcop.bsky.social @astinfo.bsky.social
AJT Transplant ID Exchange
ajt-transplant-id-exchange.squarespace.com
August 3, 2025 at 8:01 PM
Don't miss the new @amjtransplant.bsky.social #TxID blog led by Emily Blumberg ajt-transplant-id-exchange.squarespace.com #wtc2025 @ast-idcop.bsky.social @ast-tyfcop.bsky.social @astinfo.bsky.social
Excited to head to San Francisco for #WTC2025 @ast-idcop.bsky.social
August 1, 2025 at 8:30 PM
Excited to head to San Francisco for #WTC2025 @ast-idcop.bsky.social
Michael Woodward presented on utility of FMT in ICHs - can reduce risk of recurrent C diff and MDRO infections - cost, availability and lack of guidance are limiting application @fredhutch 5th Symposium on ID in ICHs.
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
May 14, 2025 at 4:35 PM
Michael Woodward presented on utility of FMT in ICHs - can reduce risk of recurrent C diff and MDRO infections - cost, availability and lack of guidance are limiting application @fredhutch 5th Symposium on ID in ICHs.
www.science.org/doi/10.1126/...
www.science.org/doi/10.1126/...
Mike Satlin gave an incredible review of MDR-GBR. These challenging bacteria cause freq infections and screening for can inform management of F&N @fredhutch.bsky.social 5th Symposium on ID in ICHs.
May 14, 2025 at 4:12 PM
Mike Satlin gave an incredible review of MDR-GBR. These challenging bacteria cause freq infections and screening for can inform management of F&N @fredhutch.bsky.social 5th Symposium on ID in ICHs.
Jay Fishman provided the keynote on Xenotransplantation- major progress but many unknowns- thankfully formal clinical trials will help inform optimal approach @fredhutch.bsky.social 5th Symposium on ID in ICHs.
May 14, 2025 at 3:39 PM
Jay Fishman provided the keynote on Xenotransplantation- major progress but many unknowns- thankfully formal clinical trials will help inform optimal approach @fredhutch.bsky.social 5th Symposium on ID in ICHs.
Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. @fredhutch.bsky.social 5th Symposium on ID in ICHs
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
May 13, 2025 at 10:44 PM
Erika Kampouri provided a masterful review of infections after CAR-T and the impact of CMV and HHV6 in these patients - HHV6 CNS disease rare, CMV needs more data to confirm optimal management. @fredhutch.bsky.social 5th Symposium on ID in ICHs
onlinelibrary.wiley.com/doi/10.1111/...
onlinelibrary.wiley.com/doi/10.1111/...
Charles Chiu @UCSF gave an amazing lecture on mNGS in immunocompromised- while helpful, limitations exist and must be recognized to interpret the results.
May 13, 2025 at 4:10 PM
Charles Chiu @UCSF gave an amazing lecture on mNGS in immunocompromised- while helpful, limitations exist and must be recognized to interpret the results.
Amazing talk on aging and infection Maheen Abidi - many questions and need for data to inform management approaches. @fredhutch.bsky.social Symposium of Infections in ICH
May 12, 2025 at 6:30 PM
Amazing talk on aging and infection Maheen Abidi - many questions and need for data to inform management approaches. @fredhutch.bsky.social Symposium of Infections in ICH
Hans Hirsch provided a master class in BKV as the keynote for the 5th @fredhutch.bsky.social Symposium on Infections in ICH. Studies have advanced our understanding of pathogens and management - but many questions remain.
May 12, 2025 at 4:24 PM
Hans Hirsch provided a master class in BKV as the keynote for the 5th @fredhutch.bsky.social Symposium on Infections in ICH. Studies have advanced our understanding of pathogens and management - but many questions remain.
Michael Boeckh highlights the grow of the the @fredhutch Symposium on Infections - matching interest the field of #TxID
It’s easy to see why with an expansion of tools to study and apply to improve outcomes in our patients!
It’s easy to see why with an expansion of tools to study and apply to improve outcomes in our patients!
May 12, 2025 at 4:18 PM
Michael Boeckh highlights the grow of the the @fredhutch Symposium on Infections - matching interest the field of #TxID
It’s easy to see why with an expansion of tools to study and apply to improve outcomes in our patients!
It’s easy to see why with an expansion of tools to study and apply to improve outcomes in our patients!
Reposted by Michael G. Ison, MD MS
Really excited to be a part of this study and see it published today!
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | New England Journal of Medicine www.nejm.org/doi/full/10....
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | New England Journal of Medicine www.nejm.org/doi/full/10....
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | NEJM
Baloxavir marboxil (baloxavir) rapidly reduces influenza virus shedding, which suggests that it may reduce transmission. Studies of treatment with neuraminidase inhibitors have not shown sufficient...
www.nejm.org
April 23, 2025 at 9:53 PM
Really excited to be a part of this study and see it published today!
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | New England Journal of Medicine www.nejm.org/doi/full/10....
Efficacy of Baloxavir Treatment in Preventing Transmission of Influenza | New England Journal of Medicine www.nejm.org/doi/full/10....
Adjuvanted RSV profusion F vaccine protection over 3 years - while VE declined over time, there remains significant protection against severe disease. More data is needed for longer term outcomes to inform optimal use.
📈 New phase 3 data presented at #ESCMIDGlobal
Efficacy, safety, and immunogenicity of the #RSV prefusion F protein vaccine in older adults over three RSV seasons
Results support a beneficial effect for at least three RSV seasons
@michaelisonmd.bsky.social
🔗 tinyurl.com/5b87kh9x
Efficacy, safety, and immunogenicity of the #RSV prefusion F protein vaccine in older adults over three RSV seasons
Results support a beneficial effect for at least three RSV seasons
@michaelisonmd.bsky.social
🔗 tinyurl.com/5b87kh9x
April 16, 2025 at 9:03 AM
Adjuvanted RSV profusion F vaccine protection over 3 years - while VE declined over time, there remains significant protection against severe disease. More data is needed for longer term outcomes to inform optimal use.
It was an honor to review the data on the link between Ureaplasma spp and Hyperammonemia in Lung Transplant recipients @ESCMID #ESCMIDGlobal 2025. Slides are here for those who want them.
www.dropbox.com/scl/fi/ei4ym...
www.dropbox.com/scl/fi/ei4ym...
www.dropbox.com
April 12, 2025 at 8:32 AM
It was an honor to review the data on the link between Ureaplasma spp and Hyperammonemia in Lung Transplant recipients @ESCMID #ESCMIDGlobal 2025. Slides are here for those who want them.
www.dropbox.com/scl/fi/ei4ym...
www.dropbox.com/scl/fi/ei4ym...
A true master class on Chagas in transplantation - emerging data supports the safety of using Chagas positive donors with careful monitoring and treatment. Marcelo Radisic #ESCMIDGlobal
April 12, 2025 at 7:48 AM
A true master class on Chagas in transplantation - emerging data supports the safety of using Chagas positive donors with careful monitoring and treatment. Marcelo Radisic #ESCMIDGlobal
Great review of TB in endemic regions including approaches to use universal prophylaxis to reduce the incidence of post-transplant infection. @RubinaNaqvi1
April 12, 2025 at 7:17 AM
Great review of TB in endemic regions including approaches to use universal prophylaxis to reduce the incidence of post-transplant infection. @RubinaNaqvi1
Great talk about HHV8 and the role of donor screening by Alesandra Mularone including follow-up management.
linkinghub.elsevier.com/retrieve/pii...
linkinghub.elsevier.com/retrieve/pii...
April 12, 2025 at 6:44 AM
Great talk about HHV8 and the role of donor screening by Alesandra Mularone including follow-up management.
linkinghub.elsevier.com/retrieve/pii...
linkinghub.elsevier.com/retrieve/pii...